The United States is in the grip of an opioid epidemic that has been aggravated by expanded use of the drug fentanyl—an extremely potent, unregulated drug often added to heroin, ecstasy, and fake OxyContin.
The American Heart Association’s Council on Quality of Care and Outcomes Research has awarded Sharon-Lise Normand the Outstanding Lifetime Achievement Award, which will be presented at their annual meeting in April 2017.
Mental health care has often been covered poorly under private health insurance—but, according to Haiden Huskamp and coauthors in an article in Health Affairs, the payment burden on consumers may be lifting.
Anupam Jena and coauthors published a research letter in JAMA Internal Medicine that identified the characteristics of those most at risk of losing coverage with repeal of the Affordable Care Act.
Tom McGuire with long-time collaborator Jacob Glazer has published a new book titled Models of Health Plan Payment and Quality Reporting that provides a comprehensive look at the research areas of optimal risk adjustment and optimal quality reporting.
An op-ed by Richard Frank and NYU’s Sherry Glied published in The Hill highlighted the Affordable Care Act’s progress fighting the national opioid epidemic.
As Congress contemplates repeal or reform of the Affordable Care Act, forecasters are busy projecting how the proposed changes to the law will affect health insurance coverage, access to care, and spending.
